Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Phase IIa Study of Vitamin D3 Tolerogenic Dendritic Cells (tolDC) for Multiple Sclerosis

University Hospital, Antwerp · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
efficacymsmultiple-sclerosispatient-safety
multiple sclerosis, tolerogenic dendritic cells, toldc, phase iia, ms, patient safety, efficacy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1008090
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.